Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: Results of a match-controlled multi-institutional analysis

European Urology

Volumn 62, Issue 3, 2012, Pages 472-487

  Briganti, Alberto ^a   Wiegel, Thomas ^b   Joniau, Steven ^c   Cozzarini, Cesare ^d   Bianchi, Marco ^a,e   Sun, Maxine ^e   Tombal, Bertrand ^f   Haustermans, Karin ^c   Budiharto, Tom ^c   Hinkelbein, Wolfgang ^g   Di Muzio, Nadia ^d   Karakiewicz, Pierre I ^e   Montorsi, Francesco ^a   Van Poppel, Hein ^c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adjuvant radiation therapy; Early salvage radiation therapy; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; EARLY SALVAGE RADIATION THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; SURVIVAL RATE;

AGED; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; EUROPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864475599     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.04.056     Document Type: Article

References (30)

1. P.I. Karakiewicz, J.A. Eastham, and M. Graefen Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients Urology 66 2005 1245 1250
2. G.P. Swanson, M. Riggs, and M. Hermans Pathologic findings at radical prostatectomy: risk factors for failure and death Urol Oncol 25 2007 110 114
3. M. Bolla, H. van Poppel, L. Collette European Organization for Research and Treatment of Cancer Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
4. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
5. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
6. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
7. F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 2005 83 94
8. G.W. Hull, F. Rabbani, F. Abbas, T.M. Wheeler, M.W. Kattan, and P.T. Scardino Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528 534
9. S.E. Cotter, M.H. Chen, and J.W. Moul Salvage radiation in men after prostate-specific antigen failure and the risk of death Cancer 117 2011 3925 3932
10. M.S. Katz, M.J. Zelefsky, E.S. Venkatraman, Z. Fuks, A. Hummer, and S.A. Leibel Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489
11. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
12. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
13. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
14. L. Vanuytsel, G. Janssens, H. Van Poppel, A. Rijnders, and L. Baert Radiotherapy for PSA recurrence after radical prostatectomy Eur Urol 39 2001 425 429
15. T. Wiegel, G. Lohm, and D. Bottke Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study Int J Radiat Oncol Biol Phys 73 2009 1009 1016
16. T.A. Stukel, E.S. Fisher, D.E. Wennberg, D.A. Alter, D.J. Gottlieb, and M.J. Vermeulen Analysis of observational studies in the presence of treatment selection bias JAMA 297 2007 278 285
17. E.J. Trabulsi, R.K. Valicenti, and A.L. Hanlon A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer Urology 72 2008 1298 1302
18. P. Ost, B. De Troyer, V. Fonteyne, W. Oosterlinck, and G. De Meerleer A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1316 1322
19. T. Budiharto, C. Perneel, and K. Haustermans A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy Radiother Oncol 97 2010 474 479
20. T.H. Van der Kwast, M. Bolla, and H. Van Poppel EORTC 22911. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186
21. L. Collette, H. van Poppel, and M. Bolla Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911) Eur J Cancer 41 2005 2662 2672
22. G.P. Swanson, B. Goldman, and C.M. Tangen The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794 J Urol 180 2008 2453 2457
23. N. Mottet, J. Bellmut, M. Bolla EAU guidelines on prostate cancer Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 59 2011 572 583
24. V. Ficarra, G. Novara, and W. Artibani Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies Eur Urol 55 2009 1037 1063
25. J.P. Mulhall, A.J. Bella, A. Briganti, A. McCullough, and G. Brock Erectile function rehabilitation in the radical prostatectomy patient J Sex Med 7 2010 1687 1698
26. C.M. Moinpour, K.A. Hayden, J.M. Unger Southwest Oncology Group Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy J Clin Oncol 26 2008 112 120
27. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (≥70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966 974
28. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
29. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
30. C. Parker, M.R. Sydes, C. Catton RADICALS Trial Management Group Radiotherapy and Androgen Deprivation in Combination After Local Surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy BJU Int 99 2007 1376 1379